RE:RE:Canntrust getting hammered for doing a public offeringAlloparc wrote: It's the pricing that's killing it, not the dilution.
15% discount. Market is repricing to match the $5.50US pricing of the placement.
quietobserver wrote: of 36.6M shares.
That was atotal kick in the nuts to the share holders of TRST to price a dilution below market.
I wonder if APHA should pick up the offering. TRST has a large medical MJ following.